Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
55 participants
INTERVENTIONAL
2020-11-02
2024-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Physiological and Sensory Responses to Prolonged Fasting in Humans
NCT05977569
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Caused by Fasting
NCT07178106
The Effects of 24-hour Fasting or Carbohydrate Restriction on Postprandial Metabolic Responses
NCT07250191
Monday is Fasting Day - Non-Randomized Trial on Intermittent Fasting
NCT02253056
Metabolic Effects of Morning 16/8 Fasting
NCT04293003
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Fasting
Starts immediately with 5 days of Buchinger fasting
Buchinger fasting
Caloric intake of \< 250 kcal/d for 5 days
Waiting list control
Starts with 5 days of Buchinger fasting after a waiting period of 12 weeks
Buchinger fasting
Caloric intake of \< 250 kcal/d for 5 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Buchinger fasting
Caloric intake of \< 250 kcal/d for 5 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 20-50 years
* Body mass index 20-30 kg/m2
Exclusion Criteria
* Any prescribed medication (except for oral contraceptives)
* Current or chronic infection
* Intake of antibiotics within 6 months before study entry
* Fasting week within 6 months before study entry
* Habitual use of dietary supplements
* Food intolerances
* Pregnancy, lactation
* Vegan diet
* Smokers
* In addition for fMRI: sensorineural hearing loss, tinnitus, metal implants, electric devices
20 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Charite University, Berlin, Germany
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Sylvia Bähring, PhD
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Sylvia Bähring, PhD
Role: PRINCIPAL_INVESTIGATOR
Charite University, Berlin, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Charité Universitätsmedizin Berlin
Berlin, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LEANER
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.